These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17001294)

  • 1. Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary intervention.
    Monraats PS; de Vries F; de Jong LW; Pons D; Sewgobind VD; Zwinderman AH; de Maat MP; 't Hart LM; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Frants RR; van der Laarse A; van der Wall EE; Wouter Jukema J
    Pharmacogenet Genomics; 2006 Oct; 16(10):747-54. PubMed ID: 17001294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention.
    Monraats PS; Kurreeman FA; Pons D; Sewgobind VD; de Vries FR; Zwinderman AH; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Huizinga TW; Eefting D; Quax PH; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
    Genes Immun; 2007 Jan; 8(1):44-50. PubMed ID: 17122782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic inflammatory factors predict restenosis after percutaneous coronary interventions.
    Monraats PS; Pires NM; Agema WR; Zwinderman AH; Schepers A; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Frants RR; Quax PH; van Vlijmen BJ; Atsma DE; van der Laarse A; van der Wall EE; Jukema JW
    Circulation; 2005 Oct; 112(16):2417-25. PubMed ID: 16230497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention.
    Monraats PS; Rana JS; Nierman MC; Pires NM; Zwinderman AH; Kastelein JJ; Kuivenhoven JA; de Maat MP; Rittersma SZ; Schepers A; Doevendans PA; de Winter RJ; Tio RA; Frants RR; Quax PH; van der Laarse A; van der Wall EE; Jukema JW
    J Am Coll Cardiol; 2005 Sep; 46(6):1093-100. PubMed ID: 16168296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interleukin 1B-511 polymorphism is associated with the risk of developing restenosis after coronary stenting in Mexican patients.
    Miranda-Malpica E; Martínez-Rios MA; Fragoso JM; Delgadillo-Rodríguez H; Rodríguez-Pérez JM; González-Quesada C; Martínez-Rodríguez N; Saldaña-Mendoza A; Peña-Duque MA; Vargas-Alarcón G
    Hum Immunol; 2008 Feb; 69(2):116-21. PubMed ID: 18361937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions.
    Pons D; Monraats PS; de Maat MP; Pires NM; Quax PH; van Vlijmen BJ; Rosendaal FR; Zwinderman AH; Doevendans PA; Waltenberger J; de Winter RJ; Tio RA; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
    Thromb Haemost; 2007 Dec; 98(6):1323-8. PubMed ID: 18064331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions.
    Hoppmann P; Koch W; Schömig A; Kastrati A
    Eur Heart J; 2004 Feb; 25(4):335-41. PubMed ID: 14984923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidate genetic markers and the risk of restenosis after coronary angioplasty.
    Völzke H; Grimm R; Robinson DM; Wolff B; Schwahn C; Hertwig S; Motz W; Rettig R
    Clin Sci (Lond); 2004 Jan; 106(1):35-42. PubMed ID: 12899665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association found between the insertion/deletion of a 287-bp alu repeat sequence within intron 16 of the angiotensin-I-converting enzyme (ACE) gene in Mexican patients and binary restenosis after coronary stenting.
    Martínez-Ríos MA; Peña-Duque MA; Fragoso JM; Delgadillo-Rodríguez H; Pérez-Hernández N; Miranda-Malpica E; Rodríguez-Pérez JM; González-Quesada C; Vargas-Alarcón G
    Clin Chim Acta; 2008 Nov; 397(1-2):65-7. PubMed ID: 18706898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activity.
    van Tiel CM; Bonta PI; Rittersma SZ; Beijk MA; Bradley EJ; Klous AM; Koch KT; Baas F; Jukema JW; Pons D; Sampietro ML; Pannekoek H; de Winter RJ; de Vries CJ
    Circulation; 2009 Aug; 120(8):669-76. PubMed ID: 19667240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention.
    Monraats PS; Fang Y; Pons D; Pires NM; Pols HA; Zwinderman AH; de Maat MP; Doevendans PA; DeWinter RJ; Tio RA; Waltenberger J; Frants RR; Quax PH; van der Laarse A; van der Wall EE; Uitterlinden AG; Jukema JW
    Expert Opin Ther Targets; 2010 Mar; 14(3):243-51. PubMed ID: 20095921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention.
    Cho HJ; Chae IH; Park KW; Ju JR; Oh S; Lee MM; Park YB
    J Hum Genet; 2002; 47(2):88-91. PubMed ID: 11916008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
    Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation.
    Canibus P; Faloia E; Piva T; Muçai A; Serenelli M; Perna GP; Boscaro M; Piva R
    Metabolism; 2008 May; 57(5):593-7. PubMed ID: 18442619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions.
    Rudez G; Pons D; Leebeek F; Monraats P; Schrevel M; Zwinderman A; de Winter R; Tio R; Doevendans P; Jukema W; de Maat M
    Hum Mutat; 2008 Mar; 29(3):375-80. PubMed ID: 18175333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P27 and P53 gene polymorphisms and restenosis following coronary implantation of drug-eluting stents.
    Tiroch K; Koch W; Mehilli J; Bottiger C; Schomig A; Kastrati A
    Cardiology; 2009; 112(4):263-9. PubMed ID: 18758183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention.
    Beijk MA; Boekholdt SM; Rittersma SZ; Pons D; Zwinderman AH; Doevendans PA; Tio RA; Tijssen JG; Jukema JW; de Winter RJ
    Pharmacogenet Genomics; 2010 Sep; 20(9):544-52. PubMed ID: 20671584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha plays an important role in restenosis development.
    Monraats PS; Pires NM; Schepers A; Agema WR; Boesten LS; de Vries MR; Zwinderman AH; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; 't Hart LM; Frants RR; Quax PH; van Vlijmen BJ; Havekes LM; van der Laarse A; van der Wall EE; Jukema JW
    FASEB J; 2005 Dec; 19(14):1998-2004. PubMed ID: 16319143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractalkine receptor polymorphisms V2491 and T280M as genetic risk factors for restenosis.
    Niessner A; Marculescu R; Kvakan H; Haschemi A; Endler G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
    Thromb Haemost; 2005 Dec; 94(6):1251-6. PubMed ID: 16411402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor alpha influences the inflammatory response after coronary surgery.
    Bittar MN; Carey JA; Barnard JB; Pravica V; Deiraniya AK; Yonan N; Hutchinson IV
    Ann Thorac Surg; 2006 Jan; 81(1):132-7. PubMed ID: 16368349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.